Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Geoffrey R. Oxnard | Researchclopedia

Back to researchers

Geoffrey R. Oxnard

Eli Lilly (United States)ORCID

993

Works

28,846

Citations

77

h-index

228

i10-index

Research Topics

Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Lung Cancer Research Studies

Affiliations

Boston University2020–2023

Brigham and Women's Hospital2012–2023

Boston Medical Center2023–2025

Beth Israel Deaconess Medical Center2013–2013

Hudson Institute2016–2016

Top Works

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Kenneth S. Thress,Cloud P. Paweletz,et al.

20151,519 citations

Lung Cancer Diagnosis and Treatment

RNA modifications and cancer

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

M.C. Liu,Geoffrey R. Oxnard,et al.

20201,446 citations

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Jason D. Merker,Geoffrey R. Oxnard,et al.

2018898 citations

Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer

Geoffrey R. Oxnard,Kenneth S. Thress,et al.

2016838 citations

Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon,Geoffrey R. Oxnard,et al.

2020819 citations

Noninvasive Detection of Response and Resistance in <i>EGFR</i> -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

Geoffrey R. Oxnard,Cloud P. Paweletz,et al.

2014776 citations

<i>MET</i> Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent <i>MET</i> Genomic Amplification and c-Met Overexpression

Mark M. Awad,Geoffrey R. Oxnard,et al.

2016681 citations

Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

Geoffrey R. Oxnard,Yuebi Hu,et al.

2018677 citations

Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer

Lecia V. Sequist,Jean‐Charles Soria,et al.

2015660 citations